Episodes
-
Adjuvant Therapy for ER-Positive Breast Cancer with Prof Stephen Johnston
November 19th, 2020 | 38 mins 58 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent data with CDK4/6 inhibitors in adjuvant therapy for ER-positive breast cancer with Prof Stephen Johnston, moderated by Neil Love, MD.
-
Management of Non-Small Cell Lung Cancer with ALK and ROS1 Rearrangements with Dr Ross Camidge
November 18th, 2020 | 39 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent data on the treatment of non-small cell lung cancer with ALK and ROS1 rearrangements with Dr Ross Camidge, moderated by Neil Love, MD.
-
Management of Gastroesophageal Cancers with Dr Daniel Catenacci
November 16th, 2020 | 42 mins 46 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion of recent data on the treatment of gastroesophageal cancers with Dr Daniel Catenacci, moderated by Neil Love, MD.
-
Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer with Dr Ashish Kamat
November 5th, 2020 | 51 mins 51 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent clinical trial data on the use of immune checkpoint inhibitors and other novel therapies in the management of urothelial bladder cancer with Dr Ashish Kamat, moderated by Neil Love, MD.
-
Renal Cell Carcinoma
November 4th, 2020 | 45 mins 10 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent data on the management of renal cell carcinoma with Dr Chung-Han Lee, moderated by Neil Love, MD.
-
Acute Myeloid Leukemia with FLT3 Mutations
October 30th, 2020 | 38 mins 5 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, leukemia, oncology, oncology education, research to practice
Featuring a discussion on recent clinical trial data on the use of FLT3 inhibitors in the management of acute myeloid leukemia with Dr Keith Pratz, moderated by Neil Love, MD.
-
Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma
October 27th, 2020 | 50 mins 22 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, lymphoma, oncology, oncology education, research to practice
Featuring a discussion on recent clinical trial data on the use of CAR T-cell therapy in the management of non-Hodgkin lymphoma with Dr Tanya Siddiqi, moderated by Neil Love, MD.
-
PARP Inhibition in the Management of Pancreatic Cancer
October 23rd, 2020 | 46 mins 40 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the use of PARP inhibitors in pancreatic cancer with Dr Kim Reiss Binder, moderated by Neil Love, MD.
-
Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy
October 21st, 2020 | 35 mins 43 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, leukemia, oncology, oncology education, research to practice
Featuring a discussion on recent data on the management of acute myeloid leukemia not eligible for intensive induction therapy with Dr Courtney DiNardo, moderated by Neil Love, MD.
-
Front-Line Treatment of Chronic Lymphocytic Leukemia
October 13th, 2020 | 54 mins 19 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, leukemia, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the first-line treatment of chronic lymphocytic leukemia with Dr John Pagel, moderated by Neil Love, MD.
-
Hodgkin Lymphoma
October 2nd, 2020 | 40 mins 59 secs
cancer, cancer treatment, chemotherapy, dr neil love, hodgkin lymphoma, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of Hodgkin lymphoma with Dr Craig Moskowitz, moderated by Neil Love, MD.
-
Novel Induction and Maintenance Strategies in Acute Myeloid Leukemia Edition
September 30th, 2020 | 52 mins 20 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, leukemia, oncology, oncology education, research to practice
Featuring a discussion of recent data with induction and maintenance therapy for acute myeloid leukemia with Jeffrey E Lancet, MD moderated by Neil Love, MD.
-
PARP Inhibitors in Breast Cancer Edition
September 23rd, 2020 | 58 mins 53 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the use of PARP inhibitors in breast cancer with Dr Susan Domchek, moderated by Neil Love, MD.
-
Oncology Today with Dr Neil Love: Myeloproliferative Neoplasms Edition
September 21st, 2020 | 41 mins 38 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of myeloproliferative neoplasms with Dr Srdan Verstovsek, moderated by Neil Love, MD.
-
Oncology Today with Dr Neil Love: EGFR Mutation-Positive Non-Small Cell Lung Cancer Edition
September 17th, 2020 | 51 mins 47 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, lung cancer, mutations, oncology, oncology education, research to practice, telemedicine
Featuring a discussion on recent advances in the treatment of EGFR mutation-positive non-small cell lung cancer with Dr Pasi Jänne, moderated by Neil Love, MD.
-
Oncology Today with Dr Neil Love: CAR T-Cell Therapy in Multiple Myeloma Edition
September 15th, 2020 | 42 mins 53 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, multiple myeloma, oncology, oncology education, research to practice
For this special edition of Oncology Today, I met with Dr Nikhil Munshi from the Dana-Farber Cancer Institute in Boston to discuss recently published and emerging research on the use of CAR T-cell therapy in multiple myeloma.